Literature DB >> 12149509

Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.

Angèle Viola1, Brigitte Chabrol, François Nicoli, Sylviane Confort-Gouny, Patrick Viout, Patrick J Cozzone.   

Abstract

Nonketotic hyperglycinemia is a life-threatening disorder in neonates characterized by a deficiency of the glycine cleavage system. We report on four cases of the neonatal form of the disease, which were investigated by in vitro(1)H magnetic resonance spectroscopy of blood and cerebrospinal fluid, and in vivo(1)H magnetic resonance spectroscopy of brain. The existence of glycine disposal pathways leading to an increase in lactate in fluids and creatine in fluids and brain was demonstrated. This is the first observation of elevated creatine in brain in nonketotic hyperglycinemia. A recurrent decrease of glutamine and citrate was observed in cerebrospinal fluid, which might be related to abnormal glutamine metabolism in brain. Finally, the cerebral N-acetylaspartate to myo-inositol-glycine ratio was identified as a prognostic indicator of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149509     DOI: 10.1203/00006450-200208000-00024

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Imaging of neurogenetic and neurometabolic disorders of childhood.

Authors:  Andrea Gropman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

2.  Neonatal nonketotic hyperglycinemia.

Authors:  Rahul P Bhamkar; Prisca Colaco
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

Review 3.  Neonatal neuroimaging findings in inborn errors of metabolism.

Authors:  Andrea Poretti; Susan I Blaser; Maarten H Lequin; Ali Fatemi; Avner Meoded; Frances J Northington; Eugen Boltshauser; Thierry A G M Huisman
Journal:  J Magn Reson Imaging       Date:  2012-05-07       Impact factor: 4.813

4.  Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.

Authors:  Raphaëlle Riché; Meijiang Liao; Izabella A Pena; Kit-Yi Leung; Nathalie Lepage; Nicolas DE Greene; Kyriakie Sarafoglou; Lisa A Schimmenti; Pierre Drapeau; Éric Samarut
Journal:  JCI Insight       Date:  2018-11-02

5.  Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.

Authors:  Marc J Kaufman; Andrew P Prescot; Dost Ongur; A Eden Evins; Tanya L Barros; Carissa L Medeiros; Julie Covell; Liqun Wang; Maurizio Fava; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-06-24       Impact factor: 3.222

6.  Sequential magnetic resonance spectroscopic changes in a patient with nonketotic hyperglycinemia.

Authors:  Ji Hun Shin; So Yoon Ahn; Jeong Hee Shin; Se In Sung; Ji Mi Jung; Jin Kyu Kim; Eun Sun Kim; Hyung Doo Park; Ji Hye Kim; Yun Sil Chang; Won Soon Park
Journal:  Korean J Pediatr       Date:  2012-08-23

7.  Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.

Authors:  Angèle Viola; Véronique Saywell; Laurent Villard; Patrick J Cozzone; Norbert W Lutz
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

8.  Detection of nonketotic hyperglycinemia in a neonate using proton magnetic resonance spectroscopy.

Authors:  Ryan Michael McAdams; Todd L Richards
Journal:  Radiol Case Rep       Date:  2015-11-06

9.  Cranial ultrasound in metabolic disorders presenting in the neonatal period: characteristic features and comparison with MR imaging.

Authors:  L M Leijser; L S de Vries; M A Rutherford; A Y Manzur; F Groenendaal; T J de Koning; M van der Heide-Jalving; F M Cowan
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

10.  High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.

Authors:  Valeria Righi; Ovidiu C Andronesi; Dionyssios Mintzopoulos; Peter M Black; A Aria Tzika
Journal:  Int J Oncol       Date:  2010-02       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.